NCT00156312View on ClinicalTrials.gov

Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

May 31, 2005

Study Completion Date

February 28, 2007

Conditions
Breast Cancer
Interventions
DRUG

Docetaxel

DRUG

Capecitabine

Trial Locations (1)

48109

University of Michigan Cancer Center, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT00156312 - Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine | Biotech Hunter | Biotech Hunter